LINCS Pilot Phase Joint Project: Sensitivity measures of six breast cancer cell lines to a library of small molecule kinase inhibitors (single drug treatments). Dataset 5 of 15: Mean cell count and mean growth rate across biological replicate 2. - Dataset - HMS LINCS Database

LINCS Pilot Phase Joint Project: Sensitivity measures of six breast cancer cell lines to a library of small molecule kinase inhibitors (single drug treatments). Dataset 5 of 15: Mean cell count and mean growth rate across biological replicate 2. - Dataset (ID:20241)

Download: Excel (XLSX), Comma-separated (CSV)

<<<<

Select the entities to show:

Small molecules	Cells

|<
<<
Previous
Page 4 of 166
Next
>>
>
76 to 100 of 4140 records
per page:

Cell	Small Molecule	Small Mol Concentration	Small Mol Conc Unit	LJP Library Plate	Timepoint	Timepoint Unit	Mean Total Cell Count Before Treatment	Mean Total Cell Count After Treatment	Mean Total Control Cell Count	Mean Relative Cell Count	Mean Relative Growth Rate After Treatment
BT-20	PD0325901	0.04	uM	LJP5	72	hr	1334	3887	3970	0.9790	0.9683
BT-20	PD0325901	0.04	uM	LJP6	72	hr	1334	3800	3970	0.9571	0.9354
BT-20	PD173074	0.04	uM	LJP6	72	hr	1334	4140	3970	1.0427	1.0643
BT-20	PD184352	0.04	uM	LJP5	72	hr	1334	4104	3970	1.0336	1.0506
BT-20	Pelitinib	0.04	uM	LJP5	72	hr	1334	3996	3970	1.0063	1.0095
BT-20	PF431396	0.04	uM	LJP5	72	hr	1334	3745	3970	0.9432	0.9144
BT-20	PF477736	0.04	uM	LJP5	72	hr	1334	3517	3970	0.8859	0.8281
BT-20	PF562271	0.04	uM	LJP6	72	hr	1334	3725	3970	0.9381	0.9067
BT-20	PHA-665752	0.04	uM	LJP5	72	hr	1334	4086	3970	1.0290	1.0437
BT-20	PHA-793887	0.04	uM	LJP6	72	hr	1334	2521	3970	0.6349	0.4500
BT-20	PI103	0.04	uM	LJP6	72	hr	1334	3878	3970	0.9768	0.9650
BT-20	PLX-4720	0.04	uM	LJP5	72	hr	1334	4142	3970	1.0432	1.0650
BT-20	QL-X-138	0.04	uM	LJP6	72	hr	1334	3221	3970	0.8113	0.7158
BT-20	QL-XII-47	0.04	uM	LJP6	72	hr	1334	3356	3970	0.8453	0.7670
BT-20	Radicicol	0.04	uM	LJP5	72	hr	1334	3362	3970	0.8468	0.7693
BT-20	Radicicol	0.04	uM	LJP6	72	hr	1334	3774	3970	0.9506	0.9256
BT-20	Seliciclib	0.04	uM	LJP5	72	hr	1334	4094	3970	1.0310	1.0467
BT-20	Ruxolitinib	0.04	uM	LJP5	72	hr	1334	4182	3970	1.0532	1.0801
BT-20	XL147	0.04	uM	LJP5	72	hr	1334	4181	3970	1.0529	1.0797
BT-20	Saracatinib	0.04	uM	LJP6	72	hr	1334	3861	3970	0.9723	0.9583
BT-20	Selumetinib	0.04	uM	LJP6	72	hr	1334	4411	3970	1.1108	1.1669
BT-20	Sirolimus	0.04	uM	LJP6	72	hr	1334	2522	3970	0.6351	0.4504
BT-20	Sorafenib	0.04	uM	LJP6	72	hr	1334	3776	3970	0.9511	0.9263
BT-20	SU11274	0.04	uM	LJP5	72	hr	1334	4275	3970	1.0766	1.1154
BT-20	Fedratinib	0.04	uM	LJP5	72	hr	1334	4137	3970	1.0418	1.0630

|<
<<
Previous
Page 4 of 166
Next
>>
>
76 to 100 of 4140 records
per page:

HMS LINCS Project

LINCS Pilot Phase Joint Project: Sensitivity measures of six breast cancer cell lines to a library of small molecule kinase inhibitors (single drug treatments). Dataset 5 of 15: Mean cell count and mean growth rate across biological replicate 2. - Dataset (ID:20241)